http://www.acc.org/Feed?clinicalTopicID=f68125ba-f38e-40e5-aa3d-65a1eea96f8e Clinical Topic Feed: Hypertension en /Latest-in-Cardiology/Articles/2026/04/01/01/Editors-Corner-Proven-Practical-Patient-First This issue brings together a set of stories united by a central theme familiar to every cardiologist: how high‑quality evidence becomes high‑value care. From prevention in childhood to advanced interventions for complex disease, each story in these pages reflects a different point along the continuum of heart health – yet all focus on turning research into meaningful, practical action. 1775046000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/01/01/Cover-Story-Renal-Denervation Few therapies in cardiovascular medicine have traveled a path as turbulent as renal denervation. Once hailed as a breakthrough for uncontrolled hypertension, the field was abruptly shaken by neutral findings from SYMPLICITY HTN-3. 1775045940000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/01/01/Prioritizing-Health-ACC26-Science ACC.26 findings aren't just resonating within the cardiology community – they're reaching patients and the wider public too. Here's a look at some of the standout studies making headlines in major consumer news outlets. 1775045700000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1775045400000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/mon-830am-thrive-acc-2026 A culturally tailored food-is-medicine intervention significantly reduced systolic blood pressure (SBP) in Black and Hispanic adults with hypertension, compared with those who received an equivalent amount of fresh produce without the additional supports, according to results from the THRIVE trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans. 1774877400000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-trifr-acc-2026 Transcatheter tricuspid edge-to-edge repair (T-TEER) in addition to standard-of-care medical therapy reduced the risk of death, myocardial infarction (MI), stroke and hospitalization for heart failure (HF) compared with standard-of-care alone in patients with severe symptomatic tricuspid regurgitation (TR)... 1774818180000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-protecth2h-acc-2026 In the first head-to-head comparison of two embolic protection devices used during TAVR, the investigational Emboliner protection catheter performed comparably to the U.S. Food and Drug Administration (FDA)-approved Sentinel cerebral protection system relative to the composite primary endpoint and secondary endpoint of stroke, according to results from the PROTECT H2H trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans. 1774818180000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-surviv-acc-2026 Among patients with a failed mitral bioprosthetic valve, transcatheter mitral valve-in-valve (mVIV) treatment was associated with a lower rate of death or disabling stroke at one year compared with standard repeat mitral valve replacement surgery (rMVR), according to results from the SURVIV study presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans. 1774818000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-1045am-cadence-acc-2026 Sotatercept, an activin signaling inhibitor, was associated with significant improvements in blood pressure and vascular health in patients with heart failure with preserved ejection fraction (HFpEF) and severe combined post and precapillary pulmonary hypertension (CpcPH), according to results of the CADENCE study presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in Circulation. 1774800360000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-830am-fastIII-acc-2026 Vessel fractional flow reserve (vFFR)-guided revascularization was noninferior to pressure-wire-based fractional flow reserve (FFR)-guided revascularization in patients with intermediate coronary lesions, according to results from the FAST III trial presented during a Late-Breaking Clinical Trials session... 1774791180000 Articles and Stories